Prolonged sterilisation of development rights supports capital-gains treatment, while business-income disallowances cannot govern capital-gains comput...
Additional evidence in transfer pricing dispute leads to fresh examination, while tax deductions, TDS credit, fee and refund interest require verifica...
Category II AIF pass-through taxation preserves non-business income character; investment receipts cannot be reclassified without applying recognised ...
Mutual fund maturity rules require proper rollover, redemption, disclosure, and due diligence; investor gains cannot excuse regulatory breaches or pen...
Threshold exemption excludes exempt services, while stamp-paper purchases avoid reverse charge; consequential service tax penalties were also set asid...
Employee conflict disclosures and investment restrictions expand with new recusal duties, post-employment limits, and compliance reporting requirement...
ELFA diagnostic kits were treated as covered by the ELISA exemption because the underlying enzyme-linked immunoassay principle remained the same and only the terminal detection method changed from colourimetric to fluorescence. The Tribunal held that strict construction of exemption entries cannot ignore scientific realities, and applied the genus-species principle and a purposive approach to conclude that technological advancement did not create a separate diagnostic class. It also held that the description of the goods as ELISA kits did not establish wilful suppression or intent to evade duty, so extended limitation was unsustainable. For the relevant period, IGST-related interest and penalty were also held not sustainable.
ELFA diagnostic kits were treated as covered by the ELISA exemption because the underlying enzyme-linked immunoassay principle remained the same and only the terminal detection method changed from colourimetric to fluorescence. The Tribunal held that strict construction of exemption entries cannot ignore scientific realities, and applied the genus-species principle and a purposive approach to conclude that technological advancement did not create a separate diagnostic class. It also held that the description of the goods as ELISA kits did not establish wilful suppression or intent to evade duty, so extended limitation was unsustainable. For the relevant period, IGST-related interest and penalty were also held not sustainable.
Note: It is a system-generated summary and is for quick reference only.